Home‎ > ‎

Clinical Trials Sarcoidosis

Rank

Status

Study

1

Suspended

Stromal Gene Expression During Pulmonary Sarcoidosis

Condition:

Sarcoidosis

Intervention:

2

Active, not recruiting

The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis

Conditions:

Sarcoidosis;   Cutaneous Sarcoidosis

Intervention:

Drug: CC-100004

3

Terminated

Trial of Adalimumab in Progressive Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: Adalimumab

4

Recruiting

Sarcoidosis With Cardiac Involvement and FDG-PET

Conditions:

Sarcoidosis;   Dilated Cardiomyopathy

Intervention:

5

Completed

Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis

Conditions:

Sarcoidosis;   Berylliosis

Intervention:

6

Active, not recruiting

Use of Armodafinil for Fatigue in Sarcoidosis

Conditions:

Sarcoidosis;   Fatigue;   Sleepiness

Interventions:

Drug: Armodafinil;   Drug: Placebo

7

Active, not recruiting

Trial of Antimycobacterial Therapy in Sarcoidosis

Condition:

Sarcoidosis

Interventions:

Drug: antibiotics;   Drug: lactose

8

Recruiting

Role of Proteomics in Diagnosing Sarcoidosis

Condition:

Sarcoidosis

Intervention:

9

Completed

Rickettsial Genesis to Sarcoidosis in Denmark

Conditions:

Sarcoidosis;   Rickettsia Infections

Intervention:

10

Completed

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

Conditions:

Pulmonary Sarcoidosis;   Lung Function

Intervention:

Drug: levaquin; ethambutol; rifampin and azithromycin.

11

Completed

Exercise Training in Sarcoidosis (EXTRAS Study)

Condition:

Sarcoidosis

Intervention:

Behavioral: High-intensity exercise training

12

Unknown

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

Conditions:

Sarcoidosis;   Pulmonary Hypertension

Intervention:

Drug: Ambrisentan

13

Completed

Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis

Conditions:

Sarcoidosis;   Mediastinal Diseases

Intervention:

Procedure: Bronchoscopy

14

Not yet recruiting

Cardiac Sarcoidosis Response To Steroids Trial

Conditions:

Cardiac Sarcoidosis;   Sarcoidosis

Intervention:

Drug: Prednisone

15

Completed

Antibody Response to Influenza Vaccine in Patients With Sarcoidosis

Condition:

Pulmonary Sarcoidosis

Intervention:

Biological: Influenza Vaccine

16

Recruiting

Trial for the Diagnosis of Sarcoidosis

Condition:

Sarcoidosis

Interventions:

Procedure: EUS-FNA/EBUS-TBNA + BAL;   Procedure: EBB + TBLB + BAL

17

Completed

Muscle Strength and Exercise Capacity in Sarcoidosis Patients

Condition:

Sarcoidosis

Intervention:

18

Enrolling by invitation

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

Conditions:

Sarcoidosis of the Heart;   Cardiomyopathy

Intervention:

19

Completed

Eye and Immunogenetic Features of Sarcoidosis

Conditions:

Sarcoidosis;   Uveitis

Intervention:

20

Recruiting

Rituximab as a Novel Therapy in Refractory Sarcoidosis: A Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: Rituximab

21

Recruiting

Atorvastatin to Treat Pulmonary Sarcoidosis

Condition:

Sarcoidosis, Pulmonary

Intervention:

Drug: Atorvastatin

22

Completed

Study of Eye Tissue for Sarcoidosis

Condition:

Sarcoidosis

Intervention:

23

Enrolling by invitation

The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis

Conditions:

Sarcoidosis;   Pulmonary Fibrosis

Intervention:

24

Terminated

Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis

Conditions:

Sarcoidosis;   Pulmonary Hypertension

Interventions:

Drug: bosentan;   Drug: placebo

25

Completed

Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis

Condition:

Sarcoidosis-Associated Ocular Inflammation

Intervention:

Procedure: Diagnostic Vitrectomy

26

Completed

The Effect of Quercetin in Sarcoidosis

Condition:

Sarcoidosis

Interventions:

Dietary Supplement: quercetin;   Other: placebo

27

Recruiting

A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis

Condition:

Sarcoidosis

Interventions:

Drug: Placebo;   Drug: ustekinumab;   Drug: golimumab

28

Completed

SARCOTHAL. Thalidomide in Skin Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: THALIDOMIDE

29

Completed

Use of Focalin for Fatigue in Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: d-methylphenidate

30

Recruiting

Efficacy of Antituberculous Therapy in Management of Sarcoidosis

Conditions:

Sarcoidosis;   Tuberculosis

Intervention:

Drug: Antituberculous therapy along with steroids

31

Completed

Treatment of Pulmonary Sarcoidosis With Pentoxifylline

Condition:

Pulmonary Sarcoidosis

Intervention:

Drug: Pentoxifylline

32

Completed

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

Conditions:

Sarcoidosis;   Pulmonary Arterial Hypertension

Intervention:

Drug: Iloprost

33

Withdrawn

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

Conditions:

Sarcoidosis;   Cutaneous Sarcoidosis

Intervention:

Drug: Humira

34

Suspended

Study of Nicotine Patches in Patients With Sarcoidosis

Condition:

Pulmonary Sarcoidosis

Intervention:

Drug: nicotine patch

35

Recruiting

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Conditions:

Sarcoidosis;   Pulmonary Arterial Hypertension

Interventions:

Drug: Bosentan;   Drug: Placebo

36

Recruiting

Tadalafil for Sarcoidosis Associated Pulmonary Hypertension

Condition:

Pulmonary Hypertension

Intervention:

Drug: Tadalafil

37

Recruiting

A Study of Adalimumab to Treat Sarcoidosis of the Skin

Condition:

Sarcoidosis

Intervention:

Drug: adalimumab

38

Completed

A Study of Infliximab in Patients With Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: Infliximab

39

Terminated

Safety Study of Abatacept to Treat Refractory Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: Abatacept

40

Withdrawn

A Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: Rituximab

41

Terminated

Mycophenolate for Pulmonary Sarcoidosis

Condition:

Pulmonary Sarcoidosis

Intervention:

Drug: Mycophenolate

42

Completed

Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Procedure: Bronchoscopy

43

Recruiting

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Procedure: Hematopoietic stem cell transplantation

44

Completed

Pathogen Specific Immunity in Patients With Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Procedure: Bronchoalveolar Lavage and Venipuncture

45

Not yet recruiting

Rehabilitation in Pulmonary Sarcoidosis: a Prospective Study

Condition:

Pulmonary Sarcoidosis

Intervention:

46

Recruiting

Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis

Conditions:

Sarcoid-associated Uveitis;   Ocular Sarcoidosis;   Macular Edema

Interventions:

Drug: Methotrexate;   Drug: Placebo

47

Withdrawn

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

Condition:

Sarcoidosis

Intervention:

Drug: adalimumab

48

Terminated

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses

Condition:

Neoplasms

Intervention:

Drug: SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin

49

Recruiting

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

Condition:

Mesothelioma

Interventions:

Drug: Pentostatin;   Drug: Cyclophosphamide;   Drug: SS1P

50

Terminated

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days

Condition:

Neoplasms

Intervention:

Drug: SS1(dsFv)-PE38

51

Completed

Sarcoidosis-associated Pulmonary Hypertension

Condition:

SARCOIDOSIS

Intervention:

52

Recruiting

A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma

Conditions:

Non-Small Cell Lung Cancer;   Adenocarcinoma

Interventions:

Drug: SS1 (dsFv) PE38;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab

53

Completed

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

Conditions:

Interstitial Lung Diseases;   Sarcoidosis;   Idiopathic Pulmonary Fibrosis;   COPD

Intervention:

54

Completed

Genetic Epidemiology of Sarcoidosis

Conditions:

Lung Diseases;   Sarcoidosis

Intervention:

55

Completed

A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)

Conditions:

Lung Diseases;   Sarcoidosis

Intervention:

56

Completed

Sarcoid Genetic Analysis (SAGA)

Conditions:

Lung Diseases;   Sarcoidosis

Intervention:

57

Completed

Salivary Proteins in Disease and Health

Conditions:

Diabetes Mellitus;   Sarcoidosis;   Dental Caries;   Sjorgren's Syndrome;   Cystinosis;   Head and Neck Neoplasms

Intervention:

58

Completed

Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient

Condition:

Sarcoidosis

Intervention:

59

Unknown †

Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery

Condition:

Malignant Mesothelioma

Interventions:

Biological: SS1(dsFv)-PE38 immunotoxin;   Drug: cisplatin;   Drug: pemetrexed disodium;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: pharmacological study;   Procedure: quality-of-life assessment

60

Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Conditions:

Interstitial Lung Diseases;   Idiopathic Pulmonary Fibrosis;   Sarcoidosis

Intervention:

61

Withdrawn

CryoSpray Ablation(tm)Thoracic Patient Registry

Conditions:

Lung Cancer;   Emphysema;   Chronic Bronchitis;   COPD;   Asthma;   Sarcoidosis;   Mesothelioma

Intervention:

62

Not yet recruiting

Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)

Conditions:

Lung Disease, Chronic Obstructive;   Lung Disease, Interstitial;   Asthma;   Sarcoidosis;   Hypertension, Pulmonary

Intervention:

63

Recruiting

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Conditions:

Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency

Intervention:

Procedure: Transplantation of Lungs After Ex-vivo Perfusion w/ STEEN Solution™

64

Unknown †

A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)

Conditions:

Isolated Mediastinal Lymphadenopathy;   Sarcoidosis;   Tuberculosis;   Lung Cancer;   Lymphoma

Intervention:

Procedure: EBUS

65

Terminated

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")

Conditions:

Benign Airway Disease;   Sarcoidosis;   Wegener's Granulomatosis;   Rhinoscleroma;   Recurrent Respiratory Papillomatosis(RRP)

Intervention:

Device: CryoSpray Ablation (tm)

66

Completed

Diffuse Fibrotic Lung Disease

Conditions:

Lung Diseases;   Pulmonary Fibrosis;   Sarcoidosis

Interventions:

Drug: prednisone;   Drug: cyclophosphamide;   Drug: dapsone

67

Recruiting

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Conditions:

Pulmonary Disease;   Oropharyngeal Disease;   Lymphangioleiomyomatosis;   Pulmonary Fibrosis;   Asthma;   Sarcoidosis

Intervention:

68

Completed

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Conditions:

Cervical Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Ovarian Cancer;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer

Intervention:

Biological: SS1(dsFv)-PE38 immunotoxin

69

Completed

Immunotoxin Therapy, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Condition:

Lung Cancer

Interventions:

Biological: SS1(dsFv)-PE38 immunotoxin;   Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Other: pharmacological study

70

Completed

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Conditions:

Cervical Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Ovarian Cancer;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer

Intervention:

Biological: SS1(dsFv)-PE38 immunotoxin

71

Unknown †

Uveitis Gene-Expression Profiling

Condition:

Uveitis

Intervention:

72

Completed

Individual Sensitivity for Interstitial Lung Diseases

Condition:

Interstitial Lung Diseases

Intervention:

73

Completed

Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy

Conditions:

Lung Cancer;   Sarcoidosis;   Tuberculosis

Interventions:

Procedure: Rapid on-site cytopathologic evaluation (ROSE);   Procedure: TBNA

74

Recruiting

Role of Genetic Factors in the Development of Lung Disease

Conditions:

Cystic Fibrosis;   Sarcoidosis;   Tuberous Sclerosis;   Asthma

Intervention:

75

Completed

Immunological Characterization of Bronchoalveolar Cells in Normals

Condition:

Lung Disease

Intervention:

76

Recruiting

Linear Endosonography for the Assessment of Sarcoidosis Stage O

Condition:

Lymphadenitis

Intervention:

Procedure: Thoracic endosonography

77

Unknown †

Database of Interstitial Lung Diseases

Condition:

Interstitial Lung Diseases

Intervention:

78

Terminated

Use of Thalidomide in Chronic Uveitis

Condition:

Uveitis

Intervention:

Drug: Thalidomide

79

Completed

Evaluation and Treatment of Patients With Inflammatory Eye Diseases

Conditions:

Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease

Intervention:

80

Terminated

Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases

Condition:

Interstitial Lung Disease

Interventions:

Drug: INS316 solution for inhalation;   Drug: hypertonic saline 3% sodium chloride solution

81

Recruiting

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Condition:

Active Uveitis That is Not From an Infection.

Interventions:

Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)

82

Completed

Low Salt Diet in Idiopathic Hypercalciuria

Condition:

Hypercalciuria

Interventions:

Behavioral: Low salt diet;   Behavioral: Water therapy alone

83

Unknown †

Pulmonary Rehabilitation in Interstitial Lung Disease

Condition:

Interstitial Lung Disease

Intervention:

Behavioral: Pulmonary Rehabilitation

84

Recruiting

Evaluation and Follow-up of Patients With Cryptococcosis

Conditions:

Cryptococcosis;   Lymphopenia

Intervention:

85

Recruiting

Safety Evaluation of Dexmedetomidine for EBUS-TBNA

Condition:

Lung Cancer

Interventions:

Drug: Remifentanil;   Drug: Dexmedetomidine

86

Terminated

Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels

Conditions:

Coronary Artery Disease;   Inflammatory Response;   Atherosclerosis

Intervention:

Dietary Supplement: eicosapentaenoic acid (EPA),

87

Completed

Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease

Condition:

Chronic Obstructive Pulmonary Disease

Intervention:

88

Completed

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

Conditions:

Asthma;   Hypersensitivity;   Lung Diseases;   Wegener's Granulomatosis

Intervention:

89

Not yet recruiting

A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma

Condition:

Exercise Induced Asthma

Intervention:

90

Recruiting

Breath Analysis by Ion Mobility Spectrometry

Condition:

Lung Diseases

Intervention:

91

Not yet recruiting

Volatile Organic Compounds (VOCs) and Liver Diseases

Condition:

Liver Diseases

Intervention:

92

Recruiting

Breath Test for Early Detection of Lung Cancer

Condition:

Lung Neoplasms

Intervention:

93

Completed

Sensitivity and Specificity of the Home Macular Perimeter (HMP)

Condition:

Age Related Macular Degeneration

Intervention:

94

Completed

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Conditions:

Major Coronary Event;   Cerebrovascular Accident;   Coronary Artery Bypass Graft;   Angina, Unstable;   Revascularization

Intervention:

Drug: Atorvastatin

http://www.clinicaltrials.gov/ct2/results?term=sarcoidosis&pg=5

http://www.clinicaltrials.gov/

 

NIH Clinical Center
... 12 noon - 1 p.m. Sarcoidosis: Clinical Presentation, Epidemiology, and Genetics Michael Iannuzzi, MD Professor and ... University Hospital, Syracuse, NY Sarcoidosis: Immunopathogenic Concepts and Their Clinical Application Joseph Fontana, MD ... 
http://www.cc.nih.gov/about/news/grandrounds/gr08/september08.html- 16.9KB - NIH Clinical Center

47%

||||||||||||||||||||

17 May 10

Find Similar

Highlight


NIH Clinical Center: Bench to Bedside Awards
... Kurlander, MD; E. Read, MD NHLBI NIAID &quotEvaluation of HMG-CoA reductase inhibitors in pulmonary sarcoidosis" Principal Translational: M. Park, MD, PhD Principal Basic:V. Manganiello, MD, PhD AI: J ... 
http://www.cc.nih.gov/ccc/btb/awards/2003.shtml- 16.1KB - NIH Clinical Center

39%

||||||||||||||||||||

31 Aug 11

Find Similar

Highlight


NIH CC: FY 2003 Bench-to-Bedside Projects
... Kurlander, MD; E. Read, MD NHLBI NIAID "Evaluation of HMG-CoA reductase inhibitors in pulmonary sarcoidosis" Principal Translational: M. Park, MD, PhD Principal Basic:V. Manganiello, MD, PhD AI: J ... 
http://www.cc.nih.gov/ccc/btb/awards/2003.html- 41.1KB - NIH Clinical Center

http://cc-web.cc.nih.gov:8080/query.html?col=wwwall&charset=iso-8859-1&style=www&qt=+sarcoidosis&image.x=0&image.y=0

http://www.cc.nih.gov/search.shtml


Comments